Shen G, Zhang W, Jia Z, Li J, Wang Q, Deng H
Department of Nuclear Medicine, West China Hospital, Sichuan University, Sichuan, China.
Br J Radiol. 2014 Dec;87(1044):20140296. doi: 10.1259/bjr.20140296. Epub 2014 Oct 28.
We performed this meta-analysis to comprehensively assess the diagnostic performance of positron emission tomography (PET) or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma (NPC).
Through a search of four English and three Chinese databases (January 1990 to June 2013), pooled estimated sensitivity, specificity and diagnostic odds ratio (DOR) were calculated based on the data extracted from the included studies. We also constructed summary receiver operating characteristic curves, with the area under the curve (AUC) and obtained the Q* index. Heterogeneity and subgroup analysis were also performed.
In total, 18 articles consisting 20 studies were included in this meta-analysis. On a per-patient basis, the overall pooled estimates for sensitivity and specificity of PET or PET/CT in N and M staging of NPC were 0.89 [95% confidence interval (CI), 0.86-0.91] and 0.96 (95% CI, 0.95-0.96), respectively. The overall DOR, AUC and Q* index were 162.07 (95% CI, 90.72-289.55), 0.9689 and 0.9181, respectively. Subgroup analysis showed that AUC and Q* index were 0.9734 and 0.9255 for N staging and 0.9715 and 0.9223 for M staging, respectively.
The present meta-analysis showed that PET or PET/CT has excellent diagnostic performance for detecting lymph node and distant metastases in patients with NPC.
To provide evidence to assess the role of PET or PET/CT in staging of NPC.
我们进行这项荟萃分析,以全面评估正电子发射断层扫描(PET)或PET/CT在检测鼻咽癌(NPC)患者淋巴结及远处转移方面的诊断性能。
通过检索四个英文数据库和三个中文数据库(1990年1月至2013年6月),根据纳入研究中提取的数据计算合并估计敏感性、特异性和诊断比值比(DOR)。我们还构建了汇总的受试者工作特征曲线,计算曲线下面积(AUC)并获得Q*指数。同时进行了异质性和亚组分析。
本荟萃分析共纳入18篇文章,包含20项研究。以患者为基础,PET或PET/CT在NPC的N和M分期中敏感性和特异性的总体合并估计值分别为0.89[95%置信区间(CI),0.86 - 0.91]和0.96(95%CI,0.95 - 0.96)。总体DOR、AUC和Q指数分别为162.07(95%CI,90.72 - 289.55)、0.9689和0.9181。亚组分析显示,N分期的AUC和Q指数分别为0.9734和0.9255,M分期的AUC和Q*指数分别为0.9715和0.9223。
本荟萃分析表明,PET或PET/CT在检测NPC患者淋巴结及远处转移方面具有出色的诊断性能。
为评估PET或PET/CT在NPC分期中的作用提供证据。